Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy
- PMID: 29422214
- DOI: 10.1016/j.ajog.2017.12.004
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy
Abstract
Small for gestational age is usually defined as an infant with a birthweight <10th centile for a population or customized standard. Fetal growth restriction refers to a fetus that has failed to reach its biological growth potential because of placental dysfunction. Small-for-gestational-age babies make up 28-45% of nonanomalous stillbirths, and have a higher chance of neurodevelopmental delay, childhood and adult obesity, and metabolic disease. The majority of small-for-gestational-age babies are not recognized before birth. Improved identification, accompanied by surveillance and timely delivery, is associated with reduction in small-for-gestational-age stillbirths. Internationally and regionally, detection of small for gestational age and management of fetal growth problems vary considerably. The aim of this review is to: summarize areas of consensus and controversy between recently published national guidelines on small for gestational age or fetal growth restriction; highlight any recent evidence that should be incorporated into existing guidelines; and identify future research priorities in this field. A search of MEDLINE, Google, and the International Guideline Library identified 6 national guidelines on management of pregnancies complicated by fetal growth restriction/small for gestational age published from 2010 onwards. There is general consensus between guidelines (at least 4 of 6 guidelines in agreement) in early pregnancy risk selection, and use of low-dose aspirin for women with major risk factors for placental insufficiency. All highlight the importance of smoking cessation to prevent small for gestational age. While there is consensus in recommending fundal height measurement in the third trimester, 3 specify the use of a customized growth chart, while 2 recommend McDonald rule. Routine third-trimester scanning is not recommended for small-for-gestational-age screening, while women with major risk factors should have serial scanning in the third trimester. Umbilical artery Doppler studies in suspected small-for-gestational-age pregnancies are universally advised, however there is inconsistency in the recommended frequency for growth scans after diagnosis of small for gestational age/fetal growth restriction (2-4 weekly). In late-onset fetal growth restriction (≥32 weeks) general consensus is to use cerebral Doppler studies to influence surveillance and/or delivery timing. Fetal surveillance methods (most recommend cardiotocography) and recommended timing of delivery vary. There is universal agreement on the use of corticosteroids before birth at <34 weeks, and general consensus on the use of magnesium sulfate for neuroprotection in early-onset fetal growth restriction (<32 weeks). Most guidelines advise using cardiotocography surveillance to plan delivery in fetal growth restriction <32 weeks. The recommended gestation at delivery for fetal growth restriction with absent and reversed end-diastolic velocity varies from 32 to ≥34 weeks and 30 to ≥34 weeks, respectively. Overall, where there is high-quality evidence from randomized controlled trials and meta-analyses, eg, use of umbilical artery Doppler and corticosteroids for delivery <34 weeks, there is a high degree of consistency between national small-for-gestational-age guidelines. This review discusses areas where there is potential for convergence between small-for-gestational-age guidelines based on existing randomized controlled trials of management of small-for-gestational-age pregnancies, and areas of controversy. Research priorities include assessing the utility of late third-trimester scanning to prevent major morbidity and mortality and to investigate the optimum timing of delivery in fetuses with late-onset fetal growth restriction and abnormal Doppler parameters. Prospective studies are needed to compare new international population ultrasound standards with those in current use.
Keywords: clinical management; fetal growth restriction; national guidelines; small for gestational age.
Copyright © 2017. Published by Elsevier Inc.
Similar articles
-
Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:10-8. doi: 10.1016/j.ejogrb.2015.06.021. Epub 2015 Jul 2. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26207980
-
Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).Am J Obstet Gynecol. 2020 Oct;223(4):B2-B17. doi: 10.1016/j.ajog.2020.05.010. Epub 2020 May 12. Am J Obstet Gynecol. 2020. PMID: 32407785
-
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.Am J Obstet Gynecol. 2022 Mar;226(3):366-378. doi: 10.1016/j.ajog.2021.11.1357. Epub 2022 Jan 10. Am J Obstet Gynecol. 2022. PMID: 35026129 Free PMC article. Review.
-
Diagnosis and surveillance of late-onset fetal growth restriction.Am J Obstet Gynecol. 2018 Feb;218(2S):S790-S802.e1. doi: 10.1016/j.ajog.2017.12.003. Am J Obstet Gynecol. 2018. PMID: 29422212 Review.
-
Fetal Growth Restriction: A Comprehensive Review of Major Guidelines.Obstet Gynecol Surv. 2023 Nov;78(11):690-708. doi: 10.1097/OGX.0000000000001203. Obstet Gynecol Surv. 2023. PMID: 38134339 Review.
Cited by
-
Prediction of Intrauterine Growth Restriction and Preeclampsia Using Machine Learning-Based Algorithms: A Prospective Study.Diagnostics (Basel). 2024 Feb 19;14(4):453. doi: 10.3390/diagnostics14040453. Diagnostics (Basel). 2024. PMID: 38396491 Free PMC article.
-
Dysfunctional Postnatal Mitochondrial Energy Metabolism in a Patient with Neurodevelopmental Defects Caused by Intrauterine Growth Restriction Due to Idiopathic Placental Insufficiency.Int J Mol Sci. 2024 Jan 23;25(3):1386. doi: 10.3390/ijms25031386. Int J Mol Sci. 2024. PMID: 38338665 Free PMC article.
-
Potential impact on using aspirin as the primary prevention of adverse pregnancy outcomes in twins conceived using ART.Sci Rep. 2024 Jan 26;14(1):2223. doi: 10.1038/s41598-024-51543-4. Sci Rep. 2024. PMID: 38278806 Free PMC article.
-
Similarity network fusion to identify phenotypes of small-for-gestational-age fetuses.iScience. 2023 Aug 12;26(9):107620. doi: 10.1016/j.isci.2023.107620. eCollection 2023 Sep 15. iScience. 2023. PMID: 37694157 Free PMC article.
-
A review of feto-placental vasculature flow modelling.Placenta. 2023 Oct;142:56-63. doi: 10.1016/j.placenta.2023.08.068. Epub 2023 Aug 22. Placenta. 2023. PMID: 37639951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources